CorDx is a multinational diagnostics company that develops, manufactures, and supplies rapid diagnostic tests and point-of-care medical device solutions. Its product portfolio spans infectious disease detection, pregnancy testing, drug screening, and biomarker detection. Proprietary diagnostics across the range hold CE Marks and approvals from regulatory bodies including the FDA. The company operates a vertically integrated supply chain and maintains manufacturing facilities in the United States as well as internationally.
With over 2,100 employees worldwide, CorDx operates across more than 100 countries and, through its broader CorDx Union network, reaches healthcare providers, families, and over a billion users in 170+ countries. The company partners with organizations globally to develop and distribute its diagnostic products at scale.
CorDx applies artificial intelligence and data science alongside conventional R&D to its diagnostics work. The company's technical domains include biotechnology, point-of-care device engineering, supply chain management, and manufacturing - areas that call for structured, process-oriented thinking alongside scientific and engineering expertise.
